
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
ProShares UltraShort Health Care (RXD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/19/2025: RXD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit -11.24% | Avg. Invested days 9 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) - | Beta -1.05 | 52 Weeks Range 9.11 - 13.64 | Updated Date 06/29/2025 |
52 Weeks Range 9.11 - 13.64 | Updated Date 06/29/2025 |
Upturn AI SWOT
ProShares UltraShort Health Care
ETF Overview
Overview
ProShares UltraShort Health Care (RXD) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. It provides leveraged inverse exposure to the health care sector.
Reputation and Reliability
ProShares is a well-known issuer of leveraged and inverse ETFs, generally considered reliable within that niche.
Management Expertise
ProShares specializes in leveraged and inverse ETFs, possessing significant experience in managing such products.
Investment Objective
Goal
To provide daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index.
Investment Approach and Strategy
Strategy: The ETF employs a leveraged inverse strategy, aiming to deliver -2x the daily performance of the Dow Jones U.S. Health Care Index.
Composition The ETF uses derivatives, such as swap agreements, to achieve its leveraged inverse exposure to the health care sector.
Market Position
Market Share: RXD's market share within the leveraged inverse health care ETF space is relatively small due to the limited number of similar products.
Total Net Assets (AUM): 23.99
Competitors
Key Competitors
- None
Competitive Landscape
RXD operates in a niche market with limited direct competitors. Its main advantage is its specific -2x leveraged inverse exposure to the health care sector. A disadvantage is the inherent risks associated with leveraged and inverse products, including potential for rapid value erosion and the effects of compounding.
Financial Performance
Historical Performance: Historical performance is highly dependent on the daily movements of the Dow Jones U.S. Health Care Index and is not suitable for long-term buy-and-hold investors.
Benchmark Comparison: The ETF's performance is designed to be -2x the daily performance of the Dow Jones U.S. Health Care Index. Deviations may occur due to fees, expenses, and the effects of compounding.
Expense Ratio: 0.95
Liquidity
Average Trading Volume
The average daily trading volume of RXD varies, but is generally moderate and may affect trading costs for large orders.
Bid-Ask Spread
The bid-ask spread can be volatile and may widen during periods of market uncertainty or low trading volume.
Market Dynamics
Market Environment Factors
RXD's performance is heavily influenced by factors affecting the health care sector, including regulatory changes, drug pricing, technological advancements, and overall market sentiment.
Growth Trajectory
RXD's growth trajectory depends on investor demand for leveraged inverse health care exposure and broader market conditions.
Moat and Competitive Advantages
Competitive Edge
RXD's primary advantage lies in its specific and targeted exposure. It provides a tool for sophisticated investors seeking to profit from short-term declines in the health care sector or hedge existing health care investments. This targeted approach allows investors to fine-tune their strategies based on short-term market views.
Risk Analysis
Volatility
RXD is highly volatile due to its leveraged and inverse nature.
Market Risk
RXD is exposed to significant market risk related to the health care sector, which can be amplified by its leveraged inverse strategy. Compounding can significantly alter the returns.
Investor Profile
Ideal Investor Profile
RXD is suitable for sophisticated investors with a high risk tolerance and a short-term investment horizon. Investors should fully understand the risks associated with leveraged and inverse ETFs before investing.
Market Risk
RXD is best suited for active traders and not for long-term investors or passive index followers.
Summary
ProShares UltraShort Health Care (RXD) offers leveraged inverse exposure to the health care sector, making it a high-risk, high-reward investment vehicle suitable for short-term trading strategies. Its performance is tied to the daily movements of the Dow Jones U.S. Health Care Index, amplified by a -2x leverage factor. The ETF is designed for sophisticated investors who understand the complexities of leveraged and inverse products and seek to profit from short-term downturns in the health care market. Due to its leveraged nature and the impact of compounding, RXD is not appropriate for long-term investment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- ProShares website
- ETF.com
- FactSet
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Investing in ETFs involves risk, including the potential loss of principal. Leveraged and inverse ETFs are not suitable for all investors. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProShares UltraShort Health Care
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.